课题基金 / 基金详情

Using ‘omics to unravel the pathophysiology and repurpose drugs to treat ME/CFS

Using ‘omics to unravel the pathophysiology and repurpose drugs to treat ME/CFS
使用组学揭示病理生理学并重新利用药物治疗 ME/CFS
批准号:
nhmrc : 1199363
负责人:
金额:
$108.3万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Targeted Calls for Research
财政年份:
2020
资助国家:
澳大利亚
项目状态:
未结题
起止时间:
2020-01-01 至 2025-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The cause(s) of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not well known, but may involve altered function by the component of the cell that produces energy (mitochondria). We will use cutting edge stem cell technology to investigate this in detail and generate vital new knowledge that could identify new targets for the treatment of ME/CFS. We will also use a complex technology to screen a library of drugs to identify those that may be useful in the treatment of ME/CFS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金